Across TCGA pan-cancer cohorts, TMEM80 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated TMEM80 data layer compared with 2 for mutation status.
The strongest signal is observed in mesothelioma (MESO), where higher TMEM80 RNA is associated with better overall survival. In most high-consensus cancer types, elevated TMEM80 expression acts as an unfavorable survival marker, although some lineages such as MESO and HNSC show a favorable association.
MESO, ACC, and HNSC are the cancer types where TMEM80 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.